|
| Thursday, November 10, 2022 |
|
|
Led by Legend Capital, PureFDA Secures Over CNY100 million in the Series B Round |
| Recently, PureFDA Medical Technology (Guangzhou) Co., LTD. (hereinafter referred to as "PureFDA") announced the completion of the Series B round of financing of over CNY100 million, which was led by Legend Capital and followed by the existing shareholder Bayland Capital. more info >> |
|
| Wednesday, November 9, 2022 |
|
|
君联资本所投企业巨子生物在港交所成功上市 |
| 据君联资本CEO Club报道，11月4日，君联资本所投企业巨子生物（2367.HK）在香港联交所主板成功上市。巨子生物拟全球发售2260.88万股，其中香港发售股份226.12万股，国际发售股份2034.76万股，另有15%超额配股权，发行价为24.3港元/股。 more info >> |
|
|
君聯資本所投企業巨子生物在港交所成功上市 |
| 據君聯資本CEO Club報道，11月4日，君聯資本所投企業巨子生物（2367.HK）在香港聯交所主板成功上市。巨子生物擬全球發售2260.88萬股，其中香港發售股份226.12萬股，國際發售股份2034.76萬股，另有15%超額配股權，發行價為24.3港元/股。 more info >> |
|
| Monday, November 7, 2022 |
|
|
Legend Capital Portfolio Company Giant Biogene Successfully Lists on the HKEX |
| On November 4, 2022, Legend Capital portfolio company Giant Biogene (2367.HK) was successfully listed on the main board of the Hong Kong Stock Exchange. more info >> |
|
| Tuesday, November 1, 2022 |
|
|
Led by Legend Capital, ClinBrain Completes Nearly CNY200 million Series C Round |
| Recently, the healthcare big data leader ClinBrain completed the Series C round of financing of nearly CNY200 million, led by Legend Capital. more info >> |
|
|
Led by Legend Capital, Easy-Flow Raises Tens of Millions of CNY in Angel Round |
| Shanghai Easy-Flow ("Easy-Flow") recently completed its Angel financing round by raising tens of millions of CNY, led by Legend Capital. The fresh capital will be used for the R&D of Easy-Flow's peripheral intervention pipeline. more info >> |
|
| Thursday, October 20, 2022 |
|
|
Co-Led by Legend Capital, Top Gene Delivery Enterprise VectorBuilder Secures CNY410mn in Series C Round |
| VectorBuilder Biotechnology (Guangzhou) Co., Ltd. (hereinafter referred to as "VectorBuilder"), a top gene delivery enterprise, recently announced the completion of its Series C round with CNY410 million, co-led by Legend Capital. more info >> |
|
| Sunday, September 25, 2022 |
|
|
GalaxySpace Completes a New Financing Round with Legend Capital Re-upped |
| GalaxySpace, a Chinese commercial aerospace company, recently completed its latest financing round with a post-investment valuation of approximately RMB11 billion. more info >> |
|
|
Leadrive Technology Completes Series C Financing, Legend Capital Re-upped |
| Leadrive Technology, a leading supplier of power semiconductor and motor control solutions for new energy vehicles, recently announced its completion of the series C financing. As the existing shareholder, Legend Capital continued to support this round of financing. more info >> |
|
| Friday, September 2, 2022 |
|
|
Legend Capital: The Logic of Technology Investment Has Changed |
| Legend Capital recently announced that it made its 100th IPO following the listing of its AI medical portfolio company Lunit on the KOSDAQ market on 21 July 2022. more info >> |
|
|
|
|
